Apelin-13 vs Vasostatin — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Apelin-13 is the most biologically active isoform of the apelin peptide family, endogenous ligands for the APJ receptor (also called APLNR). Apelin peptides are produced throughout the body, with the heart, lung, brain, and adipose tissue expressing particularly high levels....
Calculate Apelin-13 dose →Vasostatin refers to the N-terminal fragments of chromogranin A (CgA), particularly CgA1-76 (Vasostatin-1) and CgA1-113 (Vasostatin-2), generated by proteolytic processing of the chromogranin A precursor. While catestatin (CgA352-372) is the C-terminal CgA fragment with anti-cate...
Calculate Vasostatin dose →| Parameter | Apelin-13 | Vasostatin |
|---|---|---|
| Category | Cardiovascular Peptide | Cardiovascular Peptide |
| Research | Clinical | Preclinical Research |
| Half-Life | < 5 min (plasma) | ~20-30 minutes (estimated) |
| Typical Dose | 50-300 nmol/kg | 0.1-10 nmol/kg IV (animal) |
| Frequency | Variable | Acute dosing |
| Route | Intravenous (research), Subcutaneous | IV (research) |
| FDA Status | Not approved | Research compound |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.